Key Findings:  The authors of this study write: "Adolescent cannabis use has been implicated as a risk factor for schizophrenia; however, it is neither necessary nor sufficient." They further suggest that these present study results provide evidence that alterations in cannabinoid receptor interacting protein 1 (CNRIP1) may contribute to the pathophysiology of schizophrenia, as overexpression is sufficient to produce neurophysiological and behavioral correlates consistently observed in rodent models of the disease.
Type of Study:  Animal Study
Study Result:  Inconclusive
Research Location(s):  United States
Year of Pub:  2019
Cannabinoids Studied: 
Phytocannabinoid Source:  Not Applicable
Receptors Studied:  CB1
Citation:  Perez SM, et al. Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat. Schizophr Res. 2019; 206:263-270. doi: 10.1016/j.schres.2018.11.006
Authors:  Perez SM, Donegan JJ, Boley AM, Aguilar DD, Giuffrida A, Lodge DJ